acetonitrile has been researched along with HIV Coinfection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beijnen, JH; Hillebrand, MJ; Huitema, AD; Mulder, JW; Rosing, H; Ter Heine, R; van Gorp, EC | 1 |
Burger, DM; de Graaff, M; Hekster, YA; Koopmans, PP; Wuis, EW | 1 |
2 other study(ies) available for acetonitrile and HIV Coinfection
Article | Year |
---|---|
Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
Topics: Acetonitriles; Antiviral Agents; Biological Assay; Calibration; Chromatography, High Pressure Liquid; Desiccation; Drug Monitoring; Drug Stability; Drug Storage; Freezing; HIV Infections; HIV Integrase Inhibitors; Humans; Leukocytes, Mononuclear; Methanol; Molecular Structure; Particle Size; Pyrrolidinones; Raltegravir Potassium; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solutions; Tandem Mass Spectrometry; Water; Zinc Sulfate | 2009 |
Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography.
Topics: Acetonitriles; Administration, Oral; Adult; Chromatography, High Pressure Liquid; Circadian Rhythm; Drug Stability; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Male; Middle Aged; Osmolar Concentration; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Time Factors | 1997 |